Navigation Links
Dune Medical's MarginProbe™ Demonstrates Increased Positive Margin Identification Leading to Reduction in Patients Indicated for Re-excision in Landmark Lumpectomy Surgery Trial
Date:4/29/2011

d older, histologically diagnosed with carcinoma of the breast, with non-palpable malignant lesions requiring image guided localization, and undergoing lumpectomy surgery at one of 21 sites in the U.S. and Israel, were enrolled in the study.  Of these women, 596 were randomized in the operating room to one of two evenly distributed groups, either device or control.  In the device group, the MarginProbe System was used in addition to standard of care methods to measure each margin of the excised lumpectomy specimen. If the device registered a positive reading, additional tissue was immediately resected from the breast cavity corresponding to the positive margin. All tissue, in both groups, underwent intraoperative specimen imaging before being sent to routine pathology per standard of care.

A primary endpoint of the study was Complete Surgical Resection (CSR), the rate of patients with one or more positive margins (< 1mm) on the lumpectomy specimen, as determined by histology, in whom all positive margins were identified and immediately resected. In the device arm, the rate of CSR was 72 percent (N=117/163) compared to 22 percent (N=33/147) in the control group (P< 0.0001).  Total tissue volume excised across all surgeries in both groups was similar, with an average of 93cc removed in the device group compared to 85cc removed in the control group.

No safety concerns were noted in the study.  Events were similar across both study groups.

About the MarginProbe™ System

The MarginProbe System enables real time detection of cancer at or near the surface of excised tissue specimens during surgery for breast cancer. This simple and immediate assessment of the surgical margins allows surgeons to immediately excise additional tissue, potentially saving a second procedure.

The MarginProbe System is commercially available in Europe.  It is an investigational device in the United States.

'/>"/>
SOURCE Dune Medical Devices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications
2. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
3. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
4. Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies
5. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents
6. RVX-208 Data Demonstrates Increase in Functional HDL Particles
7. Antheras Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease
8. Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile
9. Sparta Systems Demonstrates Global Enterprise Quality Management Leadership at TrackWise(R) Connection User Conferences
10. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
11. First Multiple Dose Clinical Trial of TorreyPines Therapeutics Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... D.C (PRWEB) September 22, 2014 FierceBiotech ... top privately held biotechnology companies of 2014. FierceBiotech ... companies before selecting this year’s winners. Those selected ... biotechnology companies in the industry. , "It's ... new group of Fierce 15 companies," said Carroll. "This ...
(Date:9/22/2014)... 2014  Spherix Incorporated (SPEX) -- an intellectual property development ... today announced that the United States Patent & Trademark Office ... month of September that is part of a standard essential ... USRE45,121 , Application number: US 13/728,867 , ... 27, 2012 The listed inventors of the ...
(Date:9/20/2014)... 20, 2014 HealthTronics, Inc. ... interventional radiology products and services, has signed a ... Clinicon Corporation for its high precision ... of minimally invasive, mobile, surgical technology—offering more choices ... the agreement, HealthTronics will make available Clinicon’s FDA-cleared ...
(Date:9/19/2014)... that use light, rather than electricity, to move ... energy efficiency is a growing concern as chips, ... components of optical circuits light emitters, modulators, ... build. One promising light source for optical chips ... properties when deposited as a single, atom-thick layer. ...
Breaking Biology Technology:FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3Toward optical chips 2Toward optical chips 3
... July 1 Pharmasset, Inc.,(Nasdaq: VRUS ) joined ... equity indexes on June 27., Pharmasset,s membership in ... means automatic inclusion in the small-cap Russell 2000(R) Index,as ... Russell indexes,are widely used by investment managers for index ...
... Inc. ("ChromaDex"),today announced that effective June 20, 2008, ... the wholly-owned subsidiary of Cody,Resources, Inc. ("Cody") (OTC ... wholly owned by a company whose shares are ... to meet the ongoing needs,of a rapidly growing ...
... and Ben Eynon Each Assume Vice President Roles at ... ... the,market and technology leader of nanopatterning systems and solutions, today,announced that ... industry veterans are assuming the roles of vice,president of marketing and ...
Cached Biology Technology:Pharmasset Joins Russell 3000 Index 2ChromaDex, Inc. Announces Completion of Reverse Merger With Cody Resources, Inc. 2Industry Veterans Join Molecular Imprints' Management Team 2Industry Veterans Join Molecular Imprints' Management Team 3
(Date:9/22/2014)... SHELTON, Conn. , Sept. 22, 2014 ... authentication company focused on the growing mobile commerce market, ... to NASDAQ and the recent funding. ... recently completed an essential round of funding and joined ... as well as expand its other biometric and authentication ...
(Date:9/21/2014)... 22, 2014The story of cowpea (black-eyed peas) is a ... biggest problemseven more fascinating is the story of the ... Cowpea: The Food Legume of the 21st Century to ... and use. The book was recently published by the ... Institute of Tropical Agriculture (IITA). , Singh has devoted ...
(Date:9/21/2014)... previously thought, newborn immune T cells may have the ... to a new study led by King,s College London. ... of adults, babies may still be able to mount ... the journal Nature Medicine . , Our immune ... immune cells, including neutrophils which play an important role ...
Breaking Biology News(10 mins):NXT-ID Issues Shareholder Corporate Update 2NXT-ID Issues Shareholder Corporate Update 3NXT-ID Issues Shareholder Corporate Update 4Immune system of newborn babies is stronger than previously thought 2
... Sower, professor of biochemistry and director of the Center ... New Hampshire, has received a $420,000 grant from the ... pituitary hormones and receptors. With the four-year ... research in the fields of hormonal genomics and proteomics. ...
... New software developed with help from the Wildlife ... individual animals by creating a three-dimensional model using photos ... an issue of the journal Biology Letters , ... confiscated skins. The new software, developed by Conservation Research ...
... 12, 2009) Researchers from DaVinci Biosciences, Costa Mesa, ... have determined that injecting a patient,s own bone marrow-derived ... using multiple routes can be an effective treatment for ... life for SCI patients without serious adverse events. Publishing ...
Cached Biology News:Major NSF grant boosts UNH research on hormonal genomics 2Tracking tigers in 3-D 2Multiple route bone marrow stem cell injections show promise to treat spinal cord injury 2
Agar, 5 lb. Bacteriological.Moisture: < 10%, ash: < 6.5%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
Agar, 500 g. Noble Agar.Moisture: < 10%, ash: < 1.6%, EEO (-mr): < 0.450 (pH 8.4). Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
... Immunogen: Synthetic peptide derived from an ... mTOR (Mammalian target of rapamycin FRAP RAFT1 ... mTOR protein. On Western blots it ... Reactivity: Human (positive control: HEK293 cell ...
Biology Products: